Menu

Calliditas Therapeutics AB (publ) CALT

Full chart Compare
Set alert

Price alert · CALT

All alert types
40.00 +40.00

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Other Income → Expenses: $579.00KOther Operating Income → Expenses: $46.04MUS → Revenue: $1.08BExpenses → Selling, General & Admin: $1.06BExpenses → Research & Development: $499.54MExpenses → Interest Expense: $73.20MExpenses → Income Tax: $9.17MGross Profit → Expenses: $1.13BRevenue → Gross Profit: $1.13BRevenue → Cost of Revenue: $77.06MAsia → Revenue: $91.44MNet Loss → Expenses: $466.19MEurope → Revenue: $39.61MOther Income$579.00KOther Operating Income$46.04MGross Profit$1.13BNet Loss$466.19MCost of Revenue$77.06MExpenses$1.64BSelling, General & Admin$1.06BResearch & Development$499.54MInterest Expense$73.20MIncome Tax$9.17MRevenue$1.21BUS$1.08BAsia$91.44MEurope$39.61M

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

CALT annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
1.21B802.88M229.35M874.00K184.83M
119.73M77.20M25.48M106.58K19.87M
60.46M15.20M000
1.15B787.68M229.35M874.00K184.83M
1.52B1.21B753.80M380.59M212.85M
502.22M414.75M357.49M241.37M149.83M
1.06B774.66M390.23M141.72M62.88M
-373.06M-421.94M-524.46M-379.72M-28.02M
83.96M37.67M9.25M56.98M5.41M
9.17M2.85M-3.84M360.00K77.00K
-466.19M-412.27M-500.29M-433.49M-32.58M
-466.19M-412.27M-500.29M-433.49M-32.58M
-46.25M-39.64M-55.59M-52.87M-3.50M
-466.19M-412.27M-509.54M-436.51M-32.58M
-17.38-15.56-19.68-19.32-1.76
-1.72-1.50-2.19-2.36-0.189
-17.38-15.56-19.68-19.32-1.76
-373.06M-371.75M-494.88M-376.16M-27.09M
-37.01M-35.74M-54.99M-45.87M-2.91M
59.58M59.11M49.94M46.30M46.30M